Teladoc Health Inc TDOC shares are trading significantly lower in Wednesday's after-hours session after the company reported financial results.
Teladoc said first-quarter revenue increased 25% year-over-year to $565.4 million, which came in below the $568.8 million estimate. The company reported an earnings loss of $41.58 per share, which the company said was primarily driven by non-cash goodwill impairment charge of $6.6 billion ($41.11 per share).
Teladoc said it expects second-quarter revenue to be between $580 million and $600 million. The virtual healthcare company revised its full-year 2022 revenue expectations to a range of $2.4 billion to $2.5 billion versus the $2.58 billion estimate. Full-year adjusted EBITDA is expected to be between $240 million and $265 million.
TDOC 52-Week Range: $50.08 - $192.11
According to data from Benzinga Pro, the stock was down 37.5% in after hours at $34.81 at press time.
Photo: courtesy of Teladoc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.